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Three antibodies reactingwith corneal keratansul- term keratan sulfate, therefore, describes a diverse group of
fate proteoglycan were usedtodetectantigenically
polysaccharides which share thesame sulfated poly-N-acetylrelated molecules in11 bovine and13 embryonic chick lactosamine structure.
tissues. Two monoclonal antibodies recognized sulfated The presence of keratan sulfate-containing proteoglycans
epitopes on the keratan sulfate chain and a polyclonal as major components of the extracellular matrix of the cornea
antibody bound antigenic sites on the core protein of and of cartilage has been known for some time (1).More
corneal keratansulfate proteoglycan. Competitive im- recently keratan sulfate has been identified in brain (2), in
munoassay detected core protein and keratan sulfate
the skin of several marine fish (3, 4),in bone (5), in mastoantigens in guanidine HC1 extracts ofmost tissues. cytoma tumor (6), and in teratocarcinoma cells (7). Smaller
Keratan sulfate antigens of most bovine tissues were
only partially extracted with guanidine HC1,but the sulfated oligosaccharides structurally related to keratan sulremainder could be solubilized byCNBr treatment of fate have been found in lymphocytes and virus-infected chick
the guanidine-extracted residue. Keratan sulfate and embryos (8,9). Lactosaminoglycan, a nonsulfated analogue of
core protein antigens co-eluted with purified corneal keratan sulfate, has been reported in cell membrane glycoproteins of several cell types (10-12), in mucins from the gaskeratan sulfate proteoglycan on ion exchange highperformance liquid chromatography (HPLC). Endo-8-trointestinal tract and ovarian cysts (13, 14), and in extracelgalactosidase digestion of the HPLC-purified keratanlular matrix covalently linked to fibronectin (15). These resulfate antigens eliminated the binding of monoclonalports suggest that distribution of keratan sulfate-containing
anti-keratan sulfate antibodies in enzyme-linked im- proteoglycans and glycoproteins may be more widespread
munosorbent assay. Extracts of all 11 bovine tissues, than originally thought.
except those from brain and
cartilage, could bind both During the last 5 years several antibodies have been isolated
anti-keratan sulfate monoclonal antibodies and anti- to keratan sulfate and to core proteins of keratan sulfatecore protein polyclonal antibody simultaneously. Bindcontaining proteoglycans (16-23). These antibodies appear
ing was sensitive to competition with keratan sulfate highly specific (24,25) and have provided sensitive detection
and to digestion with endo-@-galactosidase. These
re- of keratan sulfate by immunohistochemistry in cultured chonsults suggest widespread occurrence of a proteoglycandrocytes (19, 26, 27) and in developing cornea and skeletal
or sulfated glycoprotein bearing keratan sulfate-like tissues (21, 28-30). Immunoassay using anti-keratan sulfate
carbohydrate and a core protein resembling that of
antibodies has been used to quantitate keratan sulfate anticorneal keratansulfate proteoglycan.
gens in human serum(31) and in extracts of developing chick

Keratan sulfate is a linearpolymer of N-acetyllactosamine
(Galpl-4GlcNAc) dissacharides joined by Dl-3 linkage (lactosaminoglycan). Keratan sulfate is sulfated at the C-6 positions of both glucosamine and galactose moieties. Proteoglycans bearing keratan sulfate chains have been characterized
in three different tissues: cornea, cartilage, and brain (1, 2).
In each of the three tissues, the core proteins of the proteoglycans are distinct, with keratan sulfate attachedto thecore
by different linkage oligosaccharides. Corneal keratan sulfate
is attached to core protein through an N-linked branched
mannose-containing oligosaccharide that is identical to that
found in complex-type oligosaccharides of neutral glycoproteins. Keratan sulfatefrom cartilage is linked to serine by an
0-glycosidic bond through galactosamine (1) and brain keratan sulfate is 0-linked to serine through mannose (2). The
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cornea (30).
In this study we used three previously characterized antibodies with reported activities against keratan sulfate proteoglycans to survey bovine and embryonic chick tissues for the
presence of antigens relatedto keratan sulfate andto corneal
KSPG’ core protein. We find that compounds antigenically
related to corneal KSPG can be detected in all tissues.
EXPERIMENTAL PROCEDURES

Materials
Purification of monoclonal antibodies I22 against rabbit corneal
keratan sulfate (16), and 5-D-4 against bovine cartilage keratan
sulfate (17) was described previously. Each of these antibodies recognizes sulfated epitopes on the keratan sulfate chains from both
cartilage and corneal keratan sulfate but not epitopes in the protein
or linkage carbohydrate (16, 17). Polyclonal rabbit antiserum against
bovine KSPG (18) was further purified by affinity for immobilized
bovine corneal KSPG (30). Purified bovine corneal keratan sulfate
was obtained from Miles Laboratories. The preparation of bovine
KSPG, desulfated bovine corneal keratan sulfate, whale cartilage
The abbreviations used are: KSPG, corneal keratan sulfate proteoglycan; ELISA, enzyme-linked immunosorbent assay; PBS, 10 mM
sodium phosphate, 0.15 M NaCl, 0.01% (w/v) thimerosal, pH 7.4;
HPLC, high-performance liquid chromatography.
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keratan sulfate (18), and of rabbit corneal keratan sulfate (16), were
described previously, as was purification of endo-@-galactosidasefrom
Escherichia freundii (32). Bovine corneal KSPG was deglycosylated
3 h at 0 "C, with trifluoromethane-sulfonic acid as described (33).
The free core protein was recovered by ion exchange HPLC as
described below. The deglycosylatedcore did not adhere to the column
and was detected by protein assay and by ELISA with the polyclonal
antibody.

Tissue Extraction
Tissues (fresh orfrozen at -70 "C) were freed of connective tissue
and fat,minced, and extracted twice, 24 h each, at 4 "C, in 10volumes
(w/v) 4 M guanidine HCl, containing protease inhibitors (0.1 M 6aminohexanoic acid, 5 mM benzamidine, 1mM phenylmethylsulfonyl
fluoride, 10 mM EDTA, 10 mM N-ethylmaleimide), 0.05 M acetate
buffer, pH 6.0, and 1% Triton X-100. Solutions were cleared by
centrifugation at l0,OOO X g for 10 min. Pooled guanidine HCl extracts
were dialyzed at 4 "Cagainst 6 M deionized urea in 20 mM Tris-HC1,
pH 6.8 with the sameproteaseinhibitors as above, then filtered
through a glass fiber filter and stored at 4 "C. Protein content of the
extract was determined with the Bio-Rad protein assay (34). Tissue
remaining afterguanidine HC1 extraction was rinsed freeof guanidine
HCI in distilled water (4-6 changes), at 4 'C then dried in a vacuum
centrifuge. Residue from 0.5 g of wet weight tissue was resuspended
in 5 ml of 70%formic acid, containing 100 mg of CNBr and incubated
capped at 25 "C overnight, vortexing occasionally. Addition of 100
mg of CNBr and a second overnight incubation was usually performed. CBNr was removed by repeated evaporation to dryness from
70% formic acid at reduced pressure. For quantitative immunoassay
the dry residue was resupended in 70% formic acid and dialyzed
against 17 mM acetic acid in the cold. For ion exchange chromatography the dried residue was resuspended directly in 6 M urea with 20
mM Tris sulfate, pH 6.8. Insoluble residue was removed by centrifugation at 10,OOO X g, 10 min.

and assayed for protein and for KSPG antigens by direct ELISA as
described above.
Endo-&galactosidase Treatment
PoolecLpeak fractions from ion exchange columns (fractions 6080) were dialyzed against 6 M urea, 20 mM Tris-sulfate, pH 6.8, and
KSPG standards were dissolved in the same solution. E. freundii
endo-@-galactosidasewas added to a finalconcentration of 0.025
units/ml, sodium acetate, pH 5.8, was added to 0.2 M, and four
protease inhibitors (16) were added. Digestion was conducted for 2 h
at room temperature. Dilutions of digests were bound onto a glutaraldehyde-treated ELISA plate and assayed with 5-D-4, 122, or polyclonal antibodies in direct ELISAas described above.
RESULTS

Comparison of Anti-keratan Sulfate Antibodies-Three previously described antibodies made to different keratan sulfatecontaining proteoglycans (16-18) were compared using whole
andpartially
degraded bovine corneal KSPG. In direct
ELISA, the two monoclonal antibodies bound to whole KSPG,
but only weakly to endo-8-galactosidase-treated KSPG. No
binding was detected to chemically deglycosylated KSPG
protein core (Fig. 1,A and B ) .This activity is consistent with
the previously determined specificity of the monoclonal antibodies for epitopes localized in keratan sulfate glycosaminoglycan chains and not
for epitopes in core protein or linkage

Immuwsays
All ELISA procedures were carried out at 25 "C, with 2-3 PBS
rinses between incubations, and dilutions were made in 1%(w/v)
bovine serum albumin, 0.1% (v/v) Tween 20 detergent inPBS (blocking buffer), except as noted.
Competitiue EUSA-Competitive ELISA using a biotin-labeled
purified corneal KSPG standard was described previously (30). Competitive assays with polyclonal antibody used biotin-labeled corneal
KSPG, affinity-purified on antibody 122-agarose as described previously for '%I-KSPG (16).
Direct ELISA-Direct ELISA was carried out by coating a polystyrene ELISA plate (Nunc 439454, Vanguard International, Neptune, NJ) with 50 pl of 0.07% glutaraldehyde freshly made in 0.1 M
phosphate, pH 5.0, for 30 min. Samples diluted to 50 pl in 6 M urea
were incubated in the wells overnight, and additional binding was
blocked by incubation with blocking buffer for 1 h. Anti-KSPG
antibody in 50 pl was added for 2 h (overnight for antibody I22 assay
of column fractions) followed by incubation with peroxidase-labeled
goat anti-moue or anti-rabbitIgG F(ab), (TAGO, Burlingame, CA)
for 1h. Color was developed with 3,3',5,5'-tetramethylbenzidine as
described (35) for 10 min.
Double AntibodyELZSA-Double antibody ELISA was carried out
by adsorption of monoclonal I22 or 5-D-4 to ELISA plates overnight
at 4 "C in 0.1 M NaHC03 buffer, pH 9. After blocking, primary
incubation was carried out for 2 h with tissue extracts diluted in
blocking buffer. Inhibition by keratan sulfate was assessed by addition
of 1 mg/ml bovine corneal keratan sulfate during the primary incubation. Sensitivity of the bound antigen to endo-&galactosidase was
assessed after primary incubation, by incubation with endo-D-galactosidase for 30 min at 37 'C as described below, omitting urea in the
buffer. Binding of polyclonal antibody to the antigen-monoclonal
antibody complex was assessed by a 2-h incubation with the diluted
antibody followedby reaction with peroxidase-labeled goat antirabbit IgG F(ab), and color development as described above.
Ion Exchange HPLC
One-half-ml aliquots of the filtered tissue extracts in6 M urea were
injected on a 1-ml Pharmacia Mono Q anion exchange HPLC column.
Elution was carried out in 6 M urea, 20 mM Tris sulfate, pH 6.8, using
a gradient of increasing slope from 0-1.5 M Na2S0, at a flow rate of
1ml per min at room temperature. Fractions of 0.3 ml were collected
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FIG. 1. Direct ELISA of corneal KSPG components. Bovine
KSPG (solid circles), endo-8-galactosidase-treated KSPG (open circles), and deglycosylatedKSPG core protein (squares and broken line)
were assayed for their ability to bind each of three antibodies by
ELISA as described under "Experimental Procedures." Error bars
show f l S.D. and are omittedif the standarddeviation was less than
the diameter of the symbol. A, antibody 122; B, antibody 5-D-4; C,
polyclonal antibody.

Keratan
Proteoglycans
Sulfate-reluted

11636

region of the keratan sulfate(16, 17).In contrast, a polyclonal
antibody to purified bovine corneal KSPG (M), affinitypurified on KSPG-agarose (30), bound KSPG and endo-&
galactosidase-treated KSPG equally well (Fig. IC). Binding
to deglycosylated KSPG core was somewhat reduced compared to whole proteoglycan (Fig. IC). The affinity-purified
polyclonal antibody, therefore, appears to recognize antigens
on thecore protein of KSPG.
In thecompetitive assay, keratan sulfate preparations from
several sources varied in ability to bind the monoclonals. As
shown in Table I, purified keratan sulfate glycosaminoglycan
preparations were weaker competitors than KSPG and also
differed in their competitive abilities according to the source
of the keratansulfate. The weakest binding to both antibodies
was from chemically desulfated keratan sulfate, confirming
the requirement for sulfation of the binding site recognized
by the monoclonal antibodies. The monoclonal antibodies
also differed from each other in relative response to each
keratan sulfate preparation, suggesting that these two antibodies may recognize slightly different sulfated epitopes in
the keratansulfate chain. MonoclonaI antibodies had no
response to heparin or otherglycosaminoglycans,nor did the
polyclonal antibody bind purified keratan sulfate or other
glycosaminoglycansin this assay (not shown).
Keratan Sulfate Antigens in Tissue Extracts-KSPG-related antigens recognized by the three antibodies were measured in extractsof several bovine and embryonic chick tissues.
As shown in Table11, antigens competing with corneal KSPG
were detected in most of the bovine tissues examined. Antigens competing for binding of the affinity-purified polyclonal
antibody were most widespread and abundant, whereas monoclonal 5-D-4 was the most restrictive in identifying KSPGrelated antigens. The amount of antigen varied widely among
tissues: cornea > cartilage >> tissues containingmuscle (skeletal and cardiac muscle, lung, and intestine). Fibrous tissue
(skin and bovine sclera) were very low in keratan sulfate
antigens but rich in core protein antigens recognized by the
polyclonal antibody. Liver consistently contained the least
KSPG antigens. In a similar survey of 13 tissues from 20-day
embryonic chick, keratan sulfate antigens were found in all
except liver and skin, with abundance distribution similar to
that of bovine tissues (not shown). The tissues surveyed were:
aorta, bone, brain, cartilage, cornea, gizzard, intestine, liver,
lung, skeletal muscle, cardiac muscle, sclera, and skin.
In many bovine tissues, part of the KSPG antigens were
not extracted by guanidine HC1, but could be solubilized by
treatment of the previously guanidine HC1-extracted tissue
with CNBr. The guanidine HC1-resistant antigen was most
abundant in striated muscle tissues, where it comprised the
majority of the total keratan sulfate antigen (99% in bovine
TABLEI
Comparison of keratan sulfate antigens with anti-keratan sulfate
morwcbnal antibodies by competitiue ELISA
Values show the amount of each type of keratan sulfate ( p g of
galactose) reouired to reduce the binding of a biotin-labeled bovine
corneal KSPG standard to 50%of uninhibited levels. Amounts were
normalized to KSPG = 1 for comparison of the two antibodies.
Keratan sulfate
trpe

Relative competitive
abilities
I22

5-D-4

~~

KSPG,
1 bovine cornea
Keratan sulfate, bovine cornea
Keratan sulfate, rabbit cornea
Keratan sulfate, whale cartilage
Desulfated keratan sulfate,
bovine cornea
"~

1
11.4 5.3
1.4
252
>loo0

5.5
51
930

cardiac muscle (Table 11)).Significant amounts of guanidine
HC1-resistant KSPG antigens were also found in bovine and
chick cornea and inbovine lung, kidney, and skin. The CNBrsolubilized antigens were typically more reactive with antibody 5-D-4 than with 122, indicating possible differences in
thestructure of keratansulfateantigensinthis
fraction
(Table 11).
Double Antibody Binding-The data in Table I1 show wide
distribution of antigens from both carbohydrate and protein
components of corneal KSPG. Table I11 demonstrates the
physical association of these two antigens in the tissue extracts by assessing the ability of the antigens to bind both
anti-keratan sulfate monoclonal and polyclonal antibodies
simultaneously. As seen in Table 111, color development was
dependent on incubation with both monoclonal and polyclonal antibodies. Competition with keratan sulfate glycosaminoglycan blocked >90% of the color development resulting
from incubation with guanidine HCl extracts andblocked 4050% of the color developed byCNBr-extracted antigensfrom
muscle and skin. Treatment of the keratan sulfate antigenantibody complex with endo-&galactosidase, resulted in a 2050% reduction of color development. These controls demonstrate specificity of the monoclonal antibody for legitimate
keratan sulfate antigensin this assay. Of bovine tissues listed
in Table 11, all but cartilage (shown) and brain (not shown)
had antigens responding in this assay. Poor response from
antigens in these two tissues would be expected because in
these two tissues keratan sulfate is linked to core proteins
different from corneal KSPG core protein. Monoclonal antibody 5-D-4 also participated in double antibody binding in a
similar manner (not shown).
Ion Exchange HPLC of the Tissue Extracts-Fig. 2 compares elution patterns of guanidine HC1 extracts of bovine
cornea and kidney tissue on anion exchange HPLC. In each
case, more than 95% of the protein in the sample was eluted
by 0.1 M sulfate. Keratan sulfate antigens, detected by ELISA,
eluted between 0.35-1.5 M sulfate in a single broad peak (Fig.
2, A and B ) . Similar elution profiles were obtained from
purified bovine corneal KSPG, aswell as from guanidine HC1
extracts of all the bovine tissues listed in Table I1 (except
from liver, which had no detectable activity). Assay with the
affinity-purified polyclonal antibody found KSPG core protein-related antigen in fractions of the gradient overlapping
the peak of keratan sulfate antigenin extracts of cornea (Fig.
2C), kidney (Fig. 2D), and all othertissues examined in Table
I1 (data not shown). For several tissues (brain, liver, cardiac
and skeletal muscle, intestine, and kidney) core protein antigen wasfound only in thehigh ionic strength elutate (e.g. Fig.
ZO), but some tissues (cornea, lung, skin, cartilage, and sclera)
also contained related antigens elutingearlier in the gradient
(as inFig. 2C).
Chromatography of CNBr-solubilized antigens of bovine
cornea andcardiac muscle is shown in Fig. 3. Keratan sulfate
antigens reacting with antibody 122, from these two samples
(Fig. 3, A and B ) , eluted in a similar manner to keratansulfate
antigens from the guanidine HCl extract shown in Fig. 2.
Antigenic components reacting with the polyclonal antibody
(Fig. 3, C and D)were found in low ionic strength eluate and
also in a typically broad peak co-eluting with the keratan
sulfate antigens. CNBr digests of bovine skeletal muscle, skin,
kidney, and lung were also chromatographed with similar
results (not shown).
Sensitivity of Keratan Sulfate Antigen to Endo-/I-galuctosidme-Fig. 4 shows endo-&galactosidase sensitivity of antigens
in pooled HPLC peak fractions of corneal guanidine HC1
extracts (Fig. 2 A ) and cardiac muscle CNBr extracts (Fig.
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TABLE
I1
Quantitative estimate of KSPG antigens in guanidine HCl extracts and CNBr digests of bovine tissues
KSPG antigens were measured in extracts and digests of tissues using the competitive ELISA, as described
under “Experimental Procedures.” Values shown indicate
the weight of bovine corneal KSPG containing the same
amount of antigen as the experimental sample. Repeatability of the assay was typically from 50 to 200% of the
values shown.Sensitivity of the assay was equivalent to -1 pg of KSPG/g of tissue (122, polyclonal) and-0.1 pg
of KSPGk of tissue (5-D-4).
Amount of antigen
Tissue

Antibody

Guanidine HCI

CNBr
g KSPG/g tissue

Guanidine HCI

CNBr

Total
”

% Total

I22
5-D-4
Polyclonal

10
0
43

0
0
0

10
0
43

100

0

100

0

Cartilage

I22
5-D-4
Polyclonal

1195
196
1653

0
7
5

1195
203
1658

100
97
100

0
3
0

Cornea

I22
5-D-4
Polyclonal

3019
3722
8154

943
1124
122

3962
4846
8276

76
77
99

24
23
1

Muscle (skeletal)

I22
5-D-4
Polyclonal

9
0
1386

144
22
144

153
22
1530

6
0
91

94
100
9

Muscle (cardiac)

I22
5-D-4
Polyclonal

1
0
249

91
9
57

92
9
306

1
0
81

99
100
19

Intestine

I22
5-D-4
Polyclonal

10
0
2000

0
0
6

10
0
2006

100

0

100

0

82

18

78

22

Brain

Kidney cortex

Kidney medulla

Liver

Lung

I22
5-D-4
Polyclonal

28
0.1
55

6
0
15

34
0.1
70

I22
5-D-4
Polyclonal

28
0
333

5
0
11

33
0
344

85

15

97

3

I22
5-D-4
Polyclonal

0
0
0

0
0
8

0
0
8

0

100

I22
5-D-4
Polyclonal

22
0.1
41

3
0.2
23

25
0.3
64

88
33
64

12
67
36

Sclera

I22
5-D-4
Polyclonal

3
1
734

0
0
27

3
1
761

100
100
96

0
0
4

Skin

I22
5-D-4
Polvclonal

3
0
1541

3
0
25

6
0
1566

50

50

3B). Reactivity in direct ELISA with both monoclonal antibodies was eliminated by endo-@-galactosidasetreatment of
the keratan sulfate antigens from both corneal and cardiac
muscle extracts (Fig. 4, A-D). Similar endo-@-galactosidase
sensitivity was found for chromatographically purified keratan sulfateantigen from allothertissues
with sufficient
antigen for assay (guanidine HC1 extracts from cartilage,
kidney, lung, and skin; CNBr extracts from skeletal muscle).
Binding of the polyclonal antibody to purified KSPG antigens in guanidine HC1 extracts from cornea (Fig. 4E),as well
as other tissues (not shown),
was not affected by endo-@galactosidase treatment. Endo-@-galactosidasetreatment of
pooled peak fractions of CNBr digests from muscle (Fig. 4F),
and other CNBrdigests, reduced but did not eliminate polyclonal antibody binding. This pattern of sensitivity demon-

98

2

strates that endo-D-galactosidasedigests the keratan sulfate
antigen withoutblocking reactivity of protein antigens in the
same fractions.
DISCUSSION

The data presented here demonstrate that proteoglycans
with antigenic and physical properties similar to corneal
KSPG can be extracted from many body tissues. The abundance and extractability of these proteoglycans vary with
respect to thetissue. We hypothesize t h d these antigens may
be a family of proteoglycans related to corneal KSPG.
All of the tissues listed in Table I1 reacted with the antikeratansulfate monoclonal antibodies inthe competitive
assay (Table 11) or in one of the direct ELISA tests (Table

Sulfate-related
Keratan
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TABLE
I11
Double antibody binding by tissue extracts

Cor ne a

Tissueextracts and digests were assayed for simultaneous binding
of polyclonal and monoclonal antibody I22 by double antibody ELISA
as described under “Experimental Procedures.” Values are averages
of four replicate data points. Values for the “complete” assay are
significantly (p < 0.025)greater than allother conditions for each
assay (except for cartilage). Abbreviations: Muscle (S),skeletal muscle. Kidney (C), kidney cortex.
Conditions of assay

Muscle

1.5

1 I. o
+

o.

Q)

s o
j
2.0

Tissue
plete

Plus
keratan
sulfate

Endo-8galactosidase

Minus
monoclonal

Minus

&

poly-

0

clonal

p”

absorbance x450 nm

1.0

4

Guanidine HC1
extracts
Cornea
Muscle (S)
Kidney (C)
Liver
Cartilage

0.894
0.872
0.195
0.186
0.007

-0.015
-0.018
0.692
0.060
-0.016
0.019
0.058
0.079

0.559
0.107
0.112
0.063

0.095
-0.001
0.002 -0.026
-0.003 -0.030
0.020 0.105

CNBr digests
Cornea
Muscle (S)
Skin

0.149
0.176
0.342

-0.027
0.108
0.168

0.042
0.084
0.261

-0.023
0.002
-0.008
0.016
-0.011 -0.017

0

Cornea

Kidnev

0

20

40

80

80

0

20

SO 8080

Fraction Number
FIG. 3. Ion exchange HPLC of CNBr extracts. CNBr digests
of bovine cornea (A and C) and of cardiac muscle ( B and D)were
fractionated by HPLC as described under “Experimental Procedures.” Data are displayed as in Fig. 2. The absorbance scale in D is
0.4 X scale values of C. Bar in D shows fractions pooled for endo-8galactosidase digestion in Fig. 4.
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FIG. 2. Ion exchange HPLC ofguanidine €IC1 tissue extracts. HPLC of the unfractionated extracts of bovine cornea ( A and
“0
10
20
0
20
40
C ) and kidney ( E and D ) was carried out in 6 M urea, 20 mM TrisSO,,with a 0-1.5 M gradient of Na2SOI as described under “Experimental Procedures.” Solid circles show direct ELISA with monoclonal
antibody I22 ( A and B ) and with polyclonal antibody (C and D).
FIG. 4. Effect of endo-&galactosidaseon KSPG antigens in
Dotted line (C and D ) shows concentration of eluting Na2S04.Dashed
lines ( A and B ) show protein concentration inmg/ml. Bar in C shows collected column fractions. Fractions 60-80 pooled from the chromatograms shown in Figs. 2C and 3 0 were treated with endo-8fractions pooled for endo-@-galactosidasedigestion in Fig. 4.
galactosidase in thepresence of protease inhibitors as described under
Procedures.” Direct ELISA of the treated (broken
111, Figs. 2 and 3). The recent literature containsan increasing “Experimental
lines) and untreated (solid lines) antigens was compared for corneal
number of reports of compounds related to keratansulfate in guanidine HCl extract (A, C, and E ) and for cardiac muscle CNBr
tissues other than cartilage and cornea. However, this study digest (B, D, and F)with three antibodies: I22 ( A and B); 5-D-4 (C
appears to be the first to suggest that some keratan sulfate and D ) ; polyclonal ( E and F). Error bars are shown as Fig. 1.

Antigen ( p l )

may be present in virtually all tissues. This discovery was
made possible by the monoclonal antibodies against keratan
sulfate. Previous characterization of these antibodies showed
that they bind sulfated regions of keratan sulfate, but not
other glycosaminoglycans, or related sulfated glycoproteins
such as mucins (17, 18,24). Recent studies with monoclonal
5-D-4 found that this antibody does not recognize fully sulfated keratan sulfate fragments shorter hexasaccharides,
than
nor are nonsulfated keratan sulfate fragments bound (24,25).
This requirement for more than two repeated sulfated lactosamine disaccharides insures that the antigens detected by
this antibody are sulfated large oligo- or polysaccharides

rather than nonsulfated lactosaminoglycans or short sulfated
lactosamine-containing oligosaccharides, such asthose of
lymphocytes and virus-infected chicken embryos (8,9).
Even though the monoclonal antibodies react with a welldefined component of keratan sulfate, the possibility exists
that thestructures recognized in tissue extracts are unknown
keratan sulfate-like carbohydrates different from the keratan
sulfate of cornea and cartilage. Sensitivity of the tissue antigens to endo-@-galactosidase,therefore, provides independent
confirmation of the poly-N-acetyllactosaminecarbohydrate
composition of these antigens. Endo-@-galactosidaseis a well-

Keratan
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characterized and highly specific enzyme requiring a minimum structure of glcNAc~(1-3)gal~(1-4)glcNAC
(32). Degradation of the antigenic material with endo-8-galactosidase
demonstrates the presence of legitimate keratan sulfatewhich
was inferred from the antibody reactivity. Together, monoclonal antibody reactivity and endo-8-galactosidase sensitivity
leave little question that the tissue antigens described here
contain oligosaccharide regions identical to the polymeric
keratan sulfate of cornea and cartilage. On the basis of the
current data, no conclusions can be drawn about the possible
presence of branched chains, the chain length, or the nature
of the protein-keratan sulfate linkage regions. These analyses
must await detailed structuralstudies on purified tissue
KSPG antigens.
The polyclonal antibody provided specificity to a completely different portion of the KSPG molecule than that
recognized by the monoclonal antibodies. Although the unfractionated antiserum does bind keratan sulfate (18), it is
clear from Fig. 1, that after affinity purification, no reactivity
with free keratan sulfate remains. Reaction with deglycosylated KSPG core (Fig. IC) suggests that the polyclonal primarily recognizes the polypeptide sequence, and not the neutral oligosaccharides, of the KSPG core protein. Further characterization of this antiserum2 found >90% of the reactivity
of purified KSPG was in endo-8-galactosidase-sensitive material. Thus, antigensrecognized bythis antibody are keratan
sulfate-linkedproteins,notunrelatedproteins
whichmay
have contaminated the KSPG originally used as immunogen.
Competitive assay with the polyclonal antibody was carried
out against alabeled KSPG standardwhich had been purified
by adsorption to immobilized antibody 122. This procedure
further insured that the antigens detected in tissue extracts
were related to keratan sulfate-linked protein of corneal
KSPG and not to contaminating
proteins.
Antigens from two separate components of corneal KSPG
(keratan sulfate andcore protein) were found widely distributed, with a generally similar abundance (Table11).A portion
of the two antigens co-chromatographs on HPLC ion exchange (Figs. 2 and3). This circumstantial evidence for
presence of these antigens in the same molecule was corroborated by the demonstration (Table 111) of a physical association of the two antigens. Specificity of this double antibody
binding for keratan sulfate was shown by sensitivity to competition with purified keratan sulfate and by sensitivity to
endo-8-galactosidase treatment of the antibody-antigen complex. An important control regarding specificity of the polyclonal antibody in this experiment was the nonreactivity of
brain and cartilage extracts, both of which contain keratan
sulfate linked to a protein core differing from that of cornea
(1, 2). These data suggest that the keratan sulfate in many
non-corneal tissues is part of a proteoglycan containing protein and keratan sulfate antigenic sites related to those of
corneal KSPG. The existence of families of proteoglycans
ranging over many tissues, containing similar or identical core
proteins, has recently been reported by Heinegard and coworkers (36). The antigens detected in our study may represent a previously undetected family of proteoglycans related
to corneal KSPG.
It is apparent from Table I1 that theproteins recognized by
the polyclonal antibody were relatively more abundant than
the keratan sulfate antigens in tissues other than cornea and
cartilage. This was most evident in fibrous tissues, such as
sclera and skin. These data suggest the presence of core
protein antigens with little or no sulfated keratan sulfate.
J. L. Funderburgh, B. Caterson, and G. W. Conrad, unpublished
observations.
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HPLC profiles of cornea (Fig. 2C), as well as those of skin
and sclera (not shown), indeed contain much material reacting
with polyclonal antibody that elutes at lower ionic strength
than does keratan sulfate. This material might be unrelated
protein containing antigenic sites in common with KSPG
core protein. On the otherhand, these datacould be explained
by the presence, in skin,sclera, and othertissues, of a KSPGlike proteoglycan that has relatively low sulfation. Its low
sulfation would result in little no
or reaction with anti-keratan
sulfate monoclonal antibodies and in elution at a low ionic
strength from the HPLC. A low ionic charge would confer
physical properties different from those of highly sulfated
proteoglycans, thus explaining why such a compound has not
been previously described.
An interesting observation of the current work is that from
some tissues KSPG antigens were marginally soluble in 4 M
guanidine HCl. Insolubility of a portion of corneal KSPG
(37), cartilage proteoglycan (38), and basement membrane
proteoglycans (39) in guanidine HCl has been reported previously. The resistance of much collagen to extraction with
guanidine HCl and its ready solubilization with CNBr suggests an association of guanidine HC1-resistant KSPG with
collagen. Recent ultrastructural studies found corneal KSPG
associated with regions of corneal collagen fibrils corresponding to theends of collagen molecules(40). This association of
KSPG with a specific portion of the corneal collagen molecules and its resistance to extraction with guanidine HCl
suggest a possible covalent collagen-KSPG link. Recent findings of covalent linkages between chondroitin sulfate and
collagen (41) and between heparan sulfate and fibronectin
(15) lend credibility to thispossibility.
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